BlackRock’s Lunai Bioworks Inc. Common Stock RENB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$779K Sell
2,698,133
-4,660,407
-63% -$1.35M ﹤0.01% 4266
2025
Q1
$4M Buy
7,358,540
+856,940
+13% +$465K ﹤0.01% 3683
2024
Q4
$5.43M Buy
6,501,600
+2,887,898
+80% +$2.41M ﹤0.01% 3646
2024
Q3
$1.75M Sell
3,613,702
-43,252
-1% -$20.9K ﹤0.01% 3986
2024
Q2
$6.4M Buy
3,656,954
+3,342,640
+1,063% +$5.85M ﹤0.01% 3546
2024
Q1
$833K Buy
314,314
+9,658
+3% +$25.6K ﹤0.01% 4186
2023
Q4
$966K Buy
304,656
+21,187
+7% +$67.2K ﹤0.01% 4192
2023
Q3
$1.27M Buy
283,469
+30,712
+12% +$137K ﹤0.01% 4102
2023
Q2
$143K Sell
252,757
-979,227
-79% -$555K ﹤0.01% 4737
2023
Q1
$1.13M Buy
1,231,984
+154,743
+14% +$142K ﹤0.01% 4215
2022
Q4
$1.11M Buy
1,077,241
+34,830
+3% +$35.9K ﹤0.01% 4299
2022
Q3
$1.89M Sell
1,042,411
-14,065
-1% -$25.5K ﹤0.01% 4137
2022
Q2
$2.04M Buy
1,056,476
+856,390
+428% +$1.65M ﹤0.01% 4163
2022
Q1
$1.65M Buy
200,086
+9,059
+5% +$74.8K ﹤0.01% 4377
2021
Q4
$1.39M Buy
191,027
+95,883
+101% +$699K ﹤0.01% 4479
2021
Q3
$640K Sell
95,144
-47,278
-33% -$318K ﹤0.01% 4625
2021
Q2
$707K Sell
142,422
-820,106
-85% -$4.07M ﹤0.01% 4540
2021
Q1
$3.41M Buy
962,528
+137,998
+17% +$488K ﹤0.01% 4044
2020
Q4
$2.43M Buy
824,530
+73,766
+10% +$218K ﹤0.01% 3902
2020
Q3
$2.69M Sell
750,764
-18,890
-2% -$67.6K ﹤0.01% 3722
2020
Q2
$3.24M Buy
769,654
+115,860
+18% +$488K ﹤0.01% 3610
2020
Q1
$1.96M Buy
653,794
+37,908
+6% +$114K ﹤0.01% 3595
2019
Q4
$3.09M Buy
615,886
+375,394
+156% +$1.88M ﹤0.01% 3592
2019
Q3
$1.32M Buy
240,492
+18,774
+8% +$103K ﹤0.01% 3831
2019
Q2
$998K Buy
221,718
+168,520
+317% +$759K ﹤0.01% 3956
2019
Q1
$369K Buy
+53,198
New +$369K ﹤0.01% 4092